1-7 of 7
Winfried Gassmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Rüdiger Hehlmann, MD, Michael Lauseker, PhD, Susanne Saussele, MD, Markus Pfirrmann, Stefan W. Krause, MD, Hans-Jochem Kolb, MD, Andreas Neubauer, MD, Dieter K. Hossfeld, Christoph Nerl, MD, Alois Gratwohl, MD, Gabriela M. Baerlocher, Dominik Heim, MD, Tim Henrik Bruemmendorf, Alice Fabarius, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martin C. Müller, MD, Sabine Jeromin, PhD, Ulrike Proetel, PhD, Katharina Kohlbrenner, PhD, Astghik Voskanyan, PhD, Sébastien Rinaldetti, Wolfgang Seifarth, PhD, Birgit Spiess, Leopold Balleisen, MD, Maria E Goebeler, MD, Mathias Hänel, MD, Anthony D. Ho, MD, J Dengler, C Falge, Lothar Kanz, MD, Claus-Henning Köhne, MD, PhD, Andreas Burchert, MD, Michael Kneba, MD PhD, Frank Stegelmann, MD, C Köhne, Hans-Walter Lindemann, C Waller, Michael Pfreundschuh, MD, Karsten Spiekermann, Wolfgang E Berdel, MD, L Müller, Matthias Edinger, MD, Jiri Mayer, Prof, MD SCs, Dietrich W Beelen, MD PhD, Martin Bentz, MD, Hartmut Link, MDPhD, Bernd Hertenstein, MD, R Fuchs, Martin Wernli, MD, F Schlegel, Rudolph Schlag, M de Wit, Lorenz Trümper, MD, H Hebarth, M Hahn, Jörg Thomalla, MD, Christof Scheid, MD, Philippe Schafhausen, MD, Walter Verbeek, MD, Michael J. Eckart, MD, Winfried Gassmann, MD PhD, Antonio Pezzutto, MD, Michael Schenk, Peter Brossart, MD, Thomas Geer, MD, Stephan Bildat, E Schäfer, Andreas Hochhaus, MD, Joerg Hasford
Journal: Blood
Blood (2017) 130 (Supplement 1): 897.
https://doi.org/10.1182/blood.V130.Suppl_1.897.897
Published: 2017
Journal Articles

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

Clinical Trials & Observations
Susanne Saußele, Marie-Paloma Krauß, Rüdiger Hehlmann, Michael Lauseker, Ulrike Proetel, Lida Kalmanti, Benjamin Hanfstein, Alice Fabarius, Doris Kraemer, Wolfgang E. Berdel, Martin Bentz, Peter Staib, Maike de Wit, Martin Wernli, Florian Zettl, Holger F. Hebart, Markus Hahn, Jochen Heymanns, Ingo Schmidt-Wolf, Norbert Schmitz, Michael J. Eckart, Winfried Gassmann, Andrea Bartholomäus, Antonio Pezzutto, Elisabeth Oppliger Leibundgut, Dominik Heim, Stefan W. Krause, Andreas Burchert, Wolf-Karsten Hofmann, Joerg Hasford, Andreas Hochhaus, Markus Pfirrmann, Martin C. Müller
Journal: Blood
Blood (2015) 126 (1): 42–49.
https://doi.org/10.1182/blood-2015-01-617993
Published: 2015
Includes: Supplemental data
Journal Articles

Imatinib (IM) and Interferon-Alpha (IFN-a) Maintenance Therapy Is Associated with Long-Term DFS in a Subset of Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Heike Pfeifer, MD, Sylvia Wystub, PhD, A. Binckebanck, Barbara Wassmann, Andreas Käbisch, Michael Lübbert, MD, Lothar Leimer, MD, Aristoteles Giagounidis, MD, Winfried Gassmann, MD, PhD, Patrick Brueck, MD, Hubert Serve, Prof. Dr. med., Dieter Hoelzer, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 1503.
https://doi.org/10.1182/blood.V120.21.1503.1503
Published: 2012
Journal Articles

Long Term Follow-up of 121 Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ALL) Treated in Prospective GMALL Trials Supports a Greater Emphasis On Allogeneic SCT as Definitive Postremission Therapy.

Heike Pfeifer, MD, Christoph Wettner, Barbara Wassmann, Aristoteles A.N. Giagounidis, Matthias Stelljes, MD, Ulrich Duehrsen, MD, Marc Schmalzing, MD, Markus Schaich, MD, Maike De Wit, Arnold Ganser, Winfried Gassmann, MD, PhD, Michael Pfreundschuh, MD, Nicolai Haertel, Knut Wendelin, MD, Mathias Schmid, MD, Hans Joachim Beck, Jolanta Dengler, MD, Heinz-August Horst, MD, Michael Lübbert, MD, Hubert Serve, Prof. Dr. med., Nicola Goekbuget, MD, Dieter Hoelzer, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 2608.
https://doi.org/10.1182/blood.V120.21.2608.2608
Published: 2012
Journal Articles

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Clinical Trials & Observations
Wolfgang Kern, Torsten Haferlach, Claudia Schoch, Helmut Löffler, Winfried Gassmann, Achim Heinecke, Maria Christina Sauerland, Wolfgang Berdel, Thomas Büchner, Wolfgang Hiddemann
Journal: Blood
Blood (2003) 101 (1): 64–70.
https://doi.org/10.1182/blood-2002-02-0532
Published: 2003
Journal Articles

Double Induction Strategy for Acute Myeloid Leukemia: The Effect of High-Dose Cytarabine With Mitoxantrone Instead of Standard-Dose Cytarabine With Daunorubicin and 6-Thioguanine: A Randomized Trial by the German AML Cooperative Group

Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann, Helmut Löffler, Winfried Gassmann, Torsten Haferlach, Christa Fonatsch, Detlef Haase, Claudia Schoch, Dieter Hossfeld, Eva Lengfelder, Carlo Aul, Axel Heyll, Georg Maschmeyer, Wolf-Dieter Ludwig, Maria-Cristina Sauerland, Achim Heinecke
Journal: Blood
Blood (1999) 93 (12): 4116–4124.
https://doi.org/10.1182/blood.V93.12.4116
Published: 1999
Journal Articles

Immunophenotypic and Genotypic Features, Clinical Characteristics, and Treatment Outcome of Adult Pro-B Acute Lymphoblastic Leukemia: Results of the German Multicenter Trials GMALL 03/87 and 04/89

Wolf-Dieter Ludwig, Harald Rieder, Claus R. Bartram, Barbara Heinze, Stefan Schwartz, Winfried Gassmann, Helmut Löffler, Dieter Hossfeld, Gerhard Heil, Susanne Handt, Axel Heyll, Helmut Diedrich, Konstanze Fischer, Adelheid Weiss, Bernd Völkers, Ülker Aydemir, Christa Fonatsch, Nicola Gökbuget, Eckhard Thiel, Dieter Hoelzer
Journal: Blood
Blood (1998) 92 (6): 1898–1909.
https://doi.org/10.1182/blood.V92.6.1898
Published: 1998